Enanta Pharmaceuticals, Inc.
Isoxazole analogs as FXR agonists and methods of use thereof
Last updated:
Abstract:
The present invention provides compounds of Formula I, ##STR00001## pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Status:
Grant
Type:
Utility
Filling date:
13 Sep 2019
Issue date:
15 Jun 2021